Evrópusambandið - íslenska - EMA (European Medicines Agency)

amgen europe b.v. - carfilzomib - mergæxli - Æxlishemjandi lyf - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.